Patents Assigned to Targent, LLC
  • NEW CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL
    Publication number: 20200270193
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
    Type: Application
    Filed: May 12, 2020
    Publication date: August 27, 2020
    Applicant: Targent, LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante
  • Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol
    Patent number: 10654783
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: May 19, 2020
    Assignee: Targent, LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante
  • NEW CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL
    Publication number: 20180362427
    Abstract: Described herein are polymorphic forms of 1,6-dibromo-1,6-dideoxy-dulcitol (dibromo dulcitol or DBD), which is a known antitumor agent. Also described are methods of making these new crystalline polymorphic forms as well as methods of using these polymorphic forms to treat cancer.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 20, 2018
    Applicant: Targent, LLC
    Inventors: Stefano Luca Giaffreda, Elena Dichiarante